These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 2644091)
1. Role of inhalation challenge testing in the diagnosis of isocyanate-induced asthma. Banks DE; Sastre J; Butcher BT; Ellis E; Rando RJ; Barkman HW; Hammad YY; Glindmeyer HW; Weill H Chest; 1989 Feb; 95(2):414-23. PubMed ID: 2644091 [TBL] [Abstract][Full Text] [Related]
2. Isocyanate-induced asthma: results of inhalation tests with TDI, MDI and methacholine. Vogelmeier C; Baur X; Fruhmann G Int Arch Occup Environ Health; 1991; 63(1):9-13. PubMed ID: 1649802 [TBL] [Abstract][Full Text] [Related]
3. Toluene diisocyanate-induced asthma without airway hyperresponsiveness. Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212 [TBL] [Abstract][Full Text] [Related]
4. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Mapp CE; Corona PC; De Marzo N; Fabbri L Am Rev Respir Dis; 1988 Jun; 137(6):1326-9. PubMed ID: 2849330 [TBL] [Abstract][Full Text] [Related]
5. Absence of hyperresponsiveness to methacholine in a worker with methylene diphenyl diisocyanate (MDI)-induced asthma. Banks DE; Barkman HW; Butcher BT; Hammad YY; Rando RJ; Glindmeyer HW; Jones RN; Weill H Chest; 1986 Mar; 89(3):389-93. PubMed ID: 3512187 [TBL] [Abstract][Full Text] [Related]
6. Persistent airways disease caused by toluene diisocyanate. Moller DR; McKay RT; Bernstein IL; Brooks SM Am Rev Respir Dis; 1986 Jul; 134(1):175-6. PubMed ID: 3014935 [TBL] [Abstract][Full Text] [Related]
11. Bronchial responsiveness to ultrasonic fog in occupational asthma due to toluene diisocyanate. Moscato G; Dellabianca A; Corsico A; Biscaldi G; Gherson G; Vinci G Chest; 1993 Oct; 104(4):1127-32. PubMed ID: 8404179 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Karol MH; Tollerud DJ; Campbell TP; Fabbri L; Maestrelli P; Saetta M; Mapp CE Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):611-5. PubMed ID: 8118626 [TBL] [Abstract][Full Text] [Related]
13. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study. Kopferschmitt-Kubler MC; Frossard N; Rohde G; Pauli G Respir Med; 1998 Sep; 92(9):1093-8. PubMed ID: 9926161 [TBL] [Abstract][Full Text] [Related]
14. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Sastre J; Fernández-Nieto M; Novalbos A; De Las Heras M; Cuesta J; Quirce S Chest; 2003 Apr; 123(4):1276-9. PubMed ID: 12684321 [TBL] [Abstract][Full Text] [Related]
15. Combined asthma and alveolitis due to diphenylmethane diisocyanate (MDI) with demonstration of no crossed respiratory reactivity to toluene diisocyanate (TDI). Mapp CE; Dal Vecchio L; Boschetto P; Fabbri LM Ann Allergy; 1985 May; 54(5):424-9. PubMed ID: 2986490 [TBL] [Abstract][Full Text] [Related]
16. Late, but not early, asthmatic reactions induced by toluene-diisocyanate are associated with increased airway responsiveness to methacholine. Mapp CE; Di Giacomo GR; Omini C; Broseghini C; Fabbri LM Eur J Respir Dis; 1986 Oct; 69(4):276-84. PubMed ID: 3028853 [TBL] [Abstract][Full Text] [Related]